Pascale Foundation, Member of Italy s Institute of Hospitalization and Treatment, Joins Caris Life Sciences Precision Oncology Alliance
News provided by
Share this article
Share this article
IRVING, Texas, April 6, 2021 /PRNewswire/ Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Istituto Nazionale Tumori IRCCS Fondazione G. Pascale (Pascale Foundation) has joined Caris Precision Oncology Alliance™ (POA). The POA is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer.
IRVING, Texas, April 6, 2021
– Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale” (Pascale Foundation) has joined Caris’ Precision Oncology Alliance™ (POA). The POA is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer. Pascale Foundation is the largest clinical care and research cancer center in Southern Italy. The institute pursues clinical research and applied research in the biomedical field, along with the organization and management of health services. Pascale Foundation focuses on patient-centered care through research and innovation in dail